Skip to main content
Clinical Trials/NCT04937946
NCT04937946
Unknown
Phase 4

Efficacy and Safety of Fentanyl for Pain Control in Newborns on Mechanical Ventilation

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh0 sites40 target enrollmentAugust 1, 2021

Overview

Phase
Phase 4
Intervention
Fentanyl
Conditions
Mechanical Ventilation Complication
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Enrollment
40
Primary Endpoint
Decrease in Neonatal Pain Agitation and Sedation Scale (NPASS) score.
Last Updated
4 years ago

Overview

Brief Summary

The purpose of the study is to assess the efficacy and safety of Fentanyl for pain control in Newborns on mechanical ventilator.

Detailed Description

This Randomized Controlled Trial will be conducted in the Department of Neonatology, BSMMU, Dhaka after approval by Institutional Review Board (IRB). A Written informed consent will be obtained before enrollment in the study from the parents or guardians. . The study cohort will comprise all inborn and outborn newborns admitted to the neonatal intensive care unit (NICU) who receive mechanical ventilation administered through an endotracheal tube . The enrolled neonates will be randomly assigned with computer-generated random number tables via software named 'Random Allocation Software', to receive either of the intervention. Once the parents will agree to the study and provide signed informed consent, all eligible neonates will be randomized to start treatment within 24 hours from the initiation of mechanical ventilation. Randomized infants will be allocated to the fentanyl group to receive a continuous infusion of fentanyl or to the placebo group to receive a continuous infusion of iv fluid. Fentanyl will be administered as an intravenous loading dose of 1 microgram/kg in 30 minutes, followed by a continuous intravenous infusion of 1μg/kg/hour. The infusion will be administered through a peripheral line. Fentanyl infusion will be initiated within 24 hours after the start of mechanical ventilation and will be continued until the end of mechanical ventilation, and not longer than 5 days .

Registry
clinicaltrials.gov
Start Date
August 1, 2021
End Date
July 1, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Responsible Party
Principal Investigator
Principal Investigator

Kundan Kumar Yadav

Resident

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Eligibility Criteria

Inclusion Criteria

  • All inborn and outborn newborns admitted to the neonatal intensive care unit (NICU) who received mechanical ventilation administered through an endotracheal tube.
  • Newborn on mechanical ventilator for at least 72 hours.

Exclusion Criteria

  • Known genetic or chromosomal disorders,
  • The need for postoperative analgesic therapy during the study period,
  • Major congenital anomaly,
  • Those who received drugs like midazolam, paracetamol, morphine, muscle relaxants, phenobarbital, phenytoin, and chloral hydrate during the study period.
  • Probable rapid extubation.

Arms & Interventions

Fentanyl

Fentanyl will be given within 24 hours from the initiation of mechanical ventilation at an intravenous loading dose of 1 microgram/kg in 30 minutes, followed by a continuous intravenous infusion of 1μg/kg/hour up to 5 days or until the end of mechanical ventilation (if interrupted before 5 days ).

Intervention: Fentanyl

Outcomes

Primary Outcomes

Decrease in Neonatal Pain Agitation and Sedation Scale (NPASS) score.

Time Frame: 5 days

If fentanyl is able to decrease NPASS pain score. Total score is 13. A mean difference of 3 points will be considered clinically relevant.

Secondary Outcomes

  • Adverse effects of fentanyl(5 days)

Similar Trials